Hello, welcome to Bioperfectus
For A Healthier Life
Dedicated to human health with a network covering more than 50 countries and regions.
A public listed company specialized in diagnostic solution of infectious diseases and many others.
Nucleic Acid Extraction Solution -
to ensure a consolidated start for PCR
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
Bioperfectus is key real-time PCR product supplier for Chinese disease prevention and control market.
Company news and information of Jiangsu Bioperfectus Technology Co. Ltd..
Reach out to us and explore more of bioPerfectus.
In face of SARS-CoV-2 variants, what is our diagnostic strategy?
Check out the video to learn about nucleic acid extraction
Navigating a healthier life, we are waiting for you to board!
Copyright © 2010-2021 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.